Skip to main navigation

    Client Main Navigation

  • Corporate
  • Patients
  • Physicians
  • Client Social Menu

    Investor Relations

  • Press Releases
  • Stock Information
    Stock Quote Stock Chart
  • SEC Filings
  • Event Calendar
  • Board & Management

    Investor Relations

  • About Us
  • Products
  • Investors
    • Press Releases
    • Stock Information
      Stock Quote Stock Chart
    • SEC Filings
    • Event Calendar
    • Board & Management
  • Patients
  • Physicians
  • Client Social Menu

Stereotaxis to be Added to the Russell 2000® and Russell 3000® Indexes

  • Read more about Stereotaxis to be Added to the Russell 2000® and Russell 3000® Indexes

Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference

  • Read more about Stereotaxis to Present at Cowen 5th Annual FutureHealth Conference

Pioneering Efforts in TeleRobotic Surgery Focus of Webcast Symposium on June 20th

  • Read more about Pioneering Efforts in TeleRobotic Surgery Focus of Webcast Symposium on June 20th

Stereotaxis Robotic Technology Now Referenced In Over 400 Scientific Publications

  • Read more about Stereotaxis Robotic Technology Now Referenced In Over 400 Scientific Publications

Stereotaxis Announces $15 Million Common Stock Financing

  • Read more about Stereotaxis Announces $15 Million Common Stock Financing

Stereotaxis Reports 2020 First Quarter Financial Results

  • Read more about Stereotaxis Reports 2020 First Quarter Financial Results

Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020

  • Read more about Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020

Stereotaxis Reports 2019 Full Year Financial Results

  • Read more about Stereotaxis Reports 2019 Full Year Financial Results

Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System

  • Read more about Stereotaxis Earns FDA Clearance and Announces U.S. Launch of Genesis Robotic Magnetic Navigation System

Q4 2019 Stereotaxis Inc. Earnings Conference Call

  • Read more about Q4 2019 Stereotaxis Inc. Earnings Conference Call

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Tweets by Stereotaxis

Receive Email Alerts

Required fields denoted by an asterisk ().
Alert type

Contact IR

Primary IR Contact
Kimberly Peery
Chief Financial Officer
Stereotaxis, Inc.
investors@stereotaxis.com

 

Transfer Agent
Broadridge Corporate Issuer Solutions
P.O. Box 1342
Brentwood, NY 11717
Phone: 855-300-4994
Fax: 215-553-5402
E-mail: shareholder@broadridge.com